In two other cases (20%), a FIP1L1-PDGFRA fusion was detected, which established the diagnosis of myeloid/lymphoid neoplasms with PDGFRA rearrangement according to the WHO 2016 classification. This evidence concerns the gene FIP1L1 and lymphoid neoplasm.